ClinicalTrials.Veeva

Menu

Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women (FiRST)

Yale University logo

Yale University

Status

Invitation-only

Conditions

Cardiac Catheterization
Percutaneous Coronary Intervention
Exercise Test
Coronary Disease
Myocardial Perfusion Imaging

Treatments

Other: No study intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04599192
2000024865

Details and patient eligibility

About

A real world study to evaluate outcomes in women based on guideline identified fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) cutoffs for ischemia (ischemia defined as FFR ≤ 0.80 and iFR ≤ 0.89).

Full description

The WOMEN FiRST (FFR iFR Revascularization Strategies Trial) study collects information from enrolled subjects to create a data repository. The data will be used to further elucidate recommendations for PCI of angiographically intermediate lesions (30-90% stenosis) in epicardial lesions in women by comparing FFR and iFR findings to findings of inducible ischemia on existing non-invasive stress imaging studies. Gender comparisons will also be made from archived and published research data sets from studies comprised up to 80% men. Data will also be stored long term for use in future undefined analyses.

Enrollment

500 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Female ≥ 18 years old at signing of informed consent
  2. Suspected myocardial ischemia or acute coronary syndrome
  3. Indication for non-invasive perfusion imaging study
  4. Indication for diagnostic catheterization
  5. Eligible for PCI
  6. Signed informed clinical procedural consent by subject or by surrogate

Exclusion criteria

  1. Inability to receive adenosine or regadenoson (for example, severe reactive airway disease, marked hypotension, or advanced atrioventricular block without pacemaker.
  2. Severe cardiomyopathy (ejection fraction <30%)
  3. Extremely tortuous or calcified coronary arteries precluding FFR/iFR measurements
  4. Patients with left main coronary artery disease requiring revascularization
  5. Female of child baring age should have negative pregnancy test
  6. Subject is pregnant or breast feeding, or planning to become pregnant
  7. Contraindication to non-invasive stress imaging including severe claustrophobia, renal disease with GFR <30 where CMR is indication, any metal in the body which is a contraindication to CMR, allergy to gadolinium contrast
  8. ICD or PPM

Trial design

500 participants in 1 patient group

Women Presenting with Cardiac Ischemia
Description:
Women presenting with cardiac ischemia as indicated by standard of care non-invasive stress testing with cardiac magnetic resonance (CMR), SPECT myocardial perfusion, and PET myocardial perfusion imaging. This cohort of women must also meet the clinical criteria to undergo coronary angiography. Women may be approached for consent either before or after their coronary angiography procedure.
Treatment:
Other: No study intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems